ArticleFrontiers in surgery2025
Case Report: Chronic subdural hematoma secondary to primary central nervous system lymphoma.
Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 69-year-old man presented with a 15-day history of right-sided motor impairment and slurred speech. Twenty-one days earlier, he was misdiagnosed at a local hospital with a routine chronic subdural hematoma (CSDH) and underwent burr-hole drainage, but his symptoms progressively worsened postoperatively, leading to aphasia and prompting his admission to our hospital. Further MRI and contrast-enhanced imaging revealed hematoma organization, brain herniation, and an intracranial mass lesion. The patient underwent craniotomy for tumor resection and evacuation of the organized hematoma. The patient received structured rehabilitation and limb positioning therapy during hospitalization to support motor recovery and prevent complications, and was discharged on postoperative day 13 with improved limb function but persistent aphasia. Histopathological analysis confirmed non-germinal center diffuse large B-cell lymphoma (DLBCL) within the hematoma, supported by immunohistochemical and FISH findings, including CD20(+), PAX-5(+), MUM-1(+), and Ki-67(+, 60%). The patient underwent four cycles of rituximab and high-dose methotrexate, resulting in lesion resolution on follow-up MRI, with motor aphasia persisting. This case represents a rare instance of primary central nervous system lymphoma (PCNSL) initially presenting as CSDH, with progression to hematoma organization and brain herniation. This case provides new insights and experience in recognizing and managing rare clinical presentations of primary central nervous system lymphoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.